These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 31123085)
21. OX40 Cooperates with ICOS To Amplify Follicular Th Cell Development and Germinal Center Reactions during Infection. Tahiliani V; Hutchinson TE; Abboud G; Croft M; Salek-Ardakani S J Immunol; 2017 Jan; 198(1):218-228. PubMed ID: 27895177 [TBL] [Abstract][Full Text] [Related]
22. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor. Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619 [TBL] [Abstract][Full Text] [Related]
23. Myocardial VHL-HIF Signaling Controls an Embryonic Metabolic Switch Essential for Cardiac Maturation. Menendez-Montes I; Escobar B; Palacios B; Gómez MJ; Izquierdo-Garcia JL; Flores L; Jiménez-Borreguero LJ; Aragones J; Ruiz-Cabello J; Torres M; Martin-Puig S Dev Cell; 2016 Dec; 39(6):724-739. PubMed ID: 27997827 [TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of the von Hippel-Lindau protein (VHL) by protein kinase CK2 reduces its protein stability and affects p53 and HIF-1alpha mediated transcription. Ampofo E; Kietzmann T; Zimmer A; Jakupovic M; Montenarh M; Götz C Int J Biochem Cell Biol; 2010 Oct; 42(10):1729-35. PubMed ID: 20637892 [TBL] [Abstract][Full Text] [Related]
25. The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma. Clifford SC; Astuti D; Hooper L; Maxwell PH; Ratcliffe PJ; Maher ER Oncogene; 2001 Aug; 20(36):5067-74. PubMed ID: 11526493 [TBL] [Abstract][Full Text] [Related]
26. Hypoxia and HIF-1alpha in chondrogenesis. Schipani E Ann N Y Acad Sci; 2006 Apr; 1068():66-73. PubMed ID: 16831906 [TBL] [Abstract][Full Text] [Related]
27. Von Hippel-Lindau tumor suppressor protein and hypoxia-inducible factor in kidney cancer. Maynard MA; Ohh M Am J Nephrol; 2004; 24(1):1-13. PubMed ID: 14654728 [TBL] [Abstract][Full Text] [Related]
28. Dynamic, site-specific interaction of hypoxia-inducible factor-1alpha with the von Hippel-Lindau tumor suppressor protein. Yu F; White SB; Zhao Q; Lee FS Cancer Res; 2001 May; 61(10):4136-42. PubMed ID: 11358837 [TBL] [Abstract][Full Text] [Related]
29. Role of the von Hippel-Lindau tumour suppressor protein in the regulation of HIF-1alpha and its oxygen-regulated transactivation domains at high cell density. Paltoglou SM; Roberts BJ Oncogene; 2005 May; 24(23):3830-5. PubMed ID: 15750626 [TBL] [Abstract][Full Text] [Related]
30. Expression of hypoxia-inducible factors in human renal cancer: relationship to angiogenesis and to the von Hippel-Lindau gene mutation. Turner KJ; Moore JW; Jones A; Taylor CF; Cuthbert-Heavens D; Han C; Leek RD; Gatter KC; Maxwell PH; Ratcliffe PJ; Cranston D; Harris AL Cancer Res; 2002 May; 62(10):2957-61. PubMed ID: 12019178 [TBL] [Abstract][Full Text] [Related]
31. TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor. Shang D; Liu Y; Yang P; Chen Y; Tian Y Urology; 2012 Apr; 79(4):966.e1-7. PubMed ID: 22341602 [TBL] [Abstract][Full Text] [Related]
32. Effect of radiation and ibuprofen on normoxic renal carcinoma cells overexpressing hypoxia-inducible factors by loss of von Hippel-Lindau tumor suppressor gene function. Palayoor ST; Burgos MA; Shoaibi A; Tofilon PJ; Coleman CN Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4158-64. PubMed ID: 15217953 [TBL] [Abstract][Full Text] [Related]
33. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612 [TBL] [Abstract][Full Text] [Related]
34. TCTP increases stability of hypoxia-inducible factor 1α by interaction with and degradation of the tumour suppressor VHL. Chen K; Chen S; Huang C; Cheng H; Zhou R Biol Cell; 2013 May; 105(5):208-218. PubMed ID: 23387829 [TBL] [Abstract][Full Text] [Related]
35. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. Blancher C; Moore JW; Robertson N; Harris AL Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776 [TBL] [Abstract][Full Text] [Related]
36. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice. Rankin EB; Higgins DF; Walisser JA; Johnson RS; Bradfield CA; Haase VH Mol Cell Biol; 2005 Apr; 25(8):3163-72. PubMed ID: 15798202 [TBL] [Abstract][Full Text] [Related]
37. The strength of BCR signaling shapes terminal development of follicular helper T cells in mice. Sacquin A; Gador M; Fazilleau N Eur J Immunol; 2017 Aug; 47(8):1295-1304. PubMed ID: 28605013 [TBL] [Abstract][Full Text] [Related]
38. Constitutive activation of hypoxia-inducible genes related to overexpression of hypoxia-inducible factor-1alpha in clear cell renal carcinomas. Wiesener MS; Münchenhagen PM; Berger I; Morgan NV; Roigas J; Schwiertz A; Jürgensen JS; Gruber G; Maxwell PH; Löning SA; Frei U; Maher ER; Gröne HJ; Eckardt KU Cancer Res; 2001 Jul; 61(13):5215-22. PubMed ID: 11431362 [TBL] [Abstract][Full Text] [Related]
39. HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Yu F; White SB; Zhao Q; Lee FS Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9630-5. PubMed ID: 11504942 [TBL] [Abstract][Full Text] [Related]
40. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease. Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]